Skip to content

A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease

a Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04347369
Enrollment
1000
Registered
2020-04-15
Start date
2020-01-17
Completion date
2020-12-31
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Disease

Brief summary

The research aim to collect large samples of COVID-19 disease patients with clinical symptoms, laboratory and imaging examination data. Screening the biological indicators which are related to the occurrence of severe diseases. Then, investigators using artificial intelligence (AI) technology deep learning method to find a prediction model that can dynamically quantify COVID-19 disease severity.

Interventions

OTHERother

clinical diagnosis

Sponsors

Xinqiao Hospital of Chongqing
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Patients of COVID-19 disease confirmed by virus nucleic acid RT-PCR and CT

Exclusion criteria

* unconfirmed suspected cases * Patients during pregnancy and lactation * incomplete clinical data * inestigators considered patients ineligible for the trial

Design outcomes

Primary

MeasureTime frameDescription
discriminationup to 3 monthsThe performance of our prediction model is evaluated with the receiver operating characteristic (ROC) curves, areas under the curves (AUCs) and concordance index (c-index).
Calibrationup to 3 monthsThe calibration curves analysis is used to show error between the predicted clinical phenotype with prediction model and actual clinical phenotype.
Net benefitup to 3 monthsDecision curve analysis was used to determine whether the models could be considered useful tools for clinical decisionmaking by comparing the net benefits at any threshold.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026